{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T06:02:28Z","timestamp":1772949748133,"version":"3.50.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017540","name":"National Heart Lung and Blood Institute Division of Intramural Research","doi-asserted-by":"publisher","award":["R01 HL136135"],"award-info":[{"award-number":["R01 HL136135"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"National Heart Lung and Blood Institute Division of Intramural Research","doi-asserted-by":"publisher","award":["R01 HL147324"],"award-info":[{"award-number":["R01 HL147324"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"National Heart Lung and Blood Institute Division of Intramural Research","doi-asserted-by":"publisher","award":["T32 HL007093"],"award-info":[{"award-number":["T32 HL007093"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000052","name":"National Institutes of Health Office of the Director","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA015704"],"award-info":[{"award-number":["P30 CA015704"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["SCR_022613"],"award-info":[{"award-number":["SCR_022613"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007812","name":"University of Washington","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007812","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Methods & Clinical Development"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.omtm.2025.101558","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T23:36:03Z","timestamp":1755128163000},"page":"101558","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Gro\u03b2T rapidly and reliably mobilizes primitive hematopoietic stem and progenitor cells in nonhuman primates"],"prefix":"10.1016","volume":"33","author":[{"given":"Andrea","family":"Repele","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dnyanada","family":"Pande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark R.","family":"Enstrom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anai Michelle","family":"Perez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravishankar","family":"Madhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronica","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Peter","family":"Kiem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2842-4820","authenticated-orcid":false,"given":"Stefan","family":"Radtke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2025.101558_bib1","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.1171242","article-title":"Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy","volume":"326","author":"Cartier","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.omtm.2025.101558_bib2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/B978-0-12-386509-0.00010-7","article-title":"Lentiviral hematopoietic cell gene therapy for X-linked adrenoleukodystrophy","volume":"507","author":"Cartier","year":"2012","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.omtm.2025.101558_bib3","article-title":"G-CSF + plerixafor versus G-CSF alone mobilized hematopoietic stem cells in patients with multiple myeloma and lymphoma: a systematic review and meta-analysis","volume":"56","author":"Li","year":"2024","journal-title":"Ann. Med."},{"key":"10.1016\/j.omtm.2025.101558_bib4","doi-asserted-by":"crossref","DOI":"10.1177\/2040206619829382","article-title":"Mozobil(R) (Plerixafor, AMD3100), 10 years after its approval by the US Food and Drug Administration","volume":"27","author":"De Clercq","year":"2019","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.omtm.2025.101558_bib5","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cytogfr.2014.07.011","article-title":"G-CSF: From granulopoietic stimulant to bone marrow stem cell mobilizing agent","volume":"25","author":"Bendall","year":"2014","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.omtm.2025.101558_bib6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.blre.2014.01.001","article-title":"Advances in stem cell mobilization","volume":"28","author":"Hopman","year":"2014","journal-title":"Blood Rev."},{"key":"10.1016\/j.omtm.2025.101558_bib7","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.exphem.2020.11.001","article-title":"AMD3100 redosing fails to repeatedly mobilize hematopoietic stem cells in the nonhuman primate and humanized mouse","volume":"93","author":"Samuelson","year":"2021","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.omtm.2025.101558_bib8","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1182\/bloodadvances.2018016725","article-title":"Successful hematopoietic stem cell mobilization and apheresis collection using plerixafor alone in sickle cell patients","volume":"2","author":"Esrick","year":"2018","journal-title":"Blood Adv."},{"key":"10.1016\/j.omtm.2025.101558_bib9","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1080\/14653240902849788","article-title":"Granulocyte colony-stimulating factor (G-CSF) administration in individuals with sickle cell disease: time for a moratorium?","volume":"11","author":"Fitzhugh","year":"2009","journal-title":"Cytotherapy"},{"key":"10.1016\/j.omtm.2025.101558_bib10","doi-asserted-by":"crossref","first-page":"338","DOI":"10.2174\/1566523217666170119113029","article-title":"Lessons learned from two decades of clinical trial experience in gene therapy for Fanconi anemia","volume":"16","author":"Adair","year":"2017","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.omtm.2025.101558_bib11","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.3324\/haematol.2018.194571","article-title":"Novel lineage depletion preserves autologous blood stem cells for gene therapy of Fanconi anemia complementation group A","volume":"103","author":"Adair","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.omtm.2025.101558_bib12","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1182\/blood-2017-07-798660","article-title":"Hematopoietic stem cell transplantation rescues the hematological, immunological, and vascular phenotype in DADA2","volume":"130","author":"Hashem","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2025.101558_bib13","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.exphem.2006.04.004","article-title":"Peripheral blood stem cell mobilization: the CXCR2 ligand GRObeta rapidly mobilizes hematopoietic stem cells with enhanced engraftment properties","volume":"34","author":"Pelus","year":"2006","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.omtm.2025.101558_bib14","doi-asserted-by":"crossref","DOI":"10.3791\/58933","article-title":"Preparation and gene modification of nonhuman primate hematopoietic stem and progenitor cells","author":"Radtke","year":"2019","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.omtm.2025.101558_bib15","first-page":"296","article-title":"Transplantation and persistence of CRISPR\/Cas9-edited hematopoietic stem and progenitors cells for the reactivation of fetal hemoglobin in nonhuman primates (Abstract)","volume":"26","author":"Humbert","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2025.101558_bib16","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1749-6632.1998.tb10460.x","article-title":"Molecular basis of hereditary persistence of fetal hemoglobin","volume":"850","author":"Forget","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.omtm.2025.101558_bib17","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan1145","article-title":"A distinct hematopoietic stem cell population for rapid multilineage engraftment in nonhuman primates","volume":"9","author":"Radtke","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2025.101558_bib18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/scrt54","article-title":"Mobilization of hematopoietic stem cells from the bone marrow niche to the blood compartment","volume":"2","author":"Hoggatt","year":"2011","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.omtm.2025.101558_bib19","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1182\/bloodadvances.2023011653","article-title":"Targeting CXCR4, VLA-4, and CXCR2 for hematopoietic stem cell mobilization","volume":"8","author":"Cancilla","year":"2024","journal-title":"Blood Adv."},{"key":"10.1016\/j.omtm.2025.101558_bib20","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1182\/blood-2008-10-184721","article-title":"BIO5192, a small molecule inhibitor of VLA-4, mobilizes hematopoietic stem and progenitor cells","volume":"114","author":"Ramirez","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2025.101558_bib21","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1172\/JCI124738","article-title":"Targeting VLA4 integrin and CXCR2 mobilizes serially repopulating hematopoietic stem cells","volume":"129","author":"Karpova","year":"2019","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omtm.2025.101558_bib22","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1016\/j.cell.2022.04.039","article-title":"Mobilization-based chemotherapy-free engraftment of gene-edited human hematopoietic stem cells","volume":"185","author":"Omer-Javed","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.omtm.2025.101558_bib23","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.stemcr.2019.09.004","article-title":"Viagra enables efficient, single-day hematopoietic stem cell mobilization","volume":"13","author":"Smith-Berdan","year":"2019","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.omtm.2025.101558_bib24","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1182\/blood-2011-07-367102","article-title":"Norepinephrine reuptake inhibition promotes mobilization in mice: potential impact to rescue low stem cell yields","volume":"119","author":"Lucas","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2025.101558_bib25","doi-asserted-by":"crossref","first-page":"770","DOI":"10.3324\/haematol.2017.187047","article-title":"Safety and efficacy of plerixafor dose escalation for the mobilization of CD34(+) hematopoietic progenitor cells in patients with sickle cell disease: interim results","volume":"103","author":"Boulad","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.omtm.2025.101558_bib26","doi-asserted-by":"crossref","first-page":"778","DOI":"10.3324\/haematol.2017.184788","article-title":"Plerixafor enables safe, rapid, efficient mobilization of hematopoietic stem cells in sickle cell disease patients after exchange transfusion","volume":"103","author":"Lagresle-Peyrou","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.omtm.2025.101558_bib27","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.bbmt.2006.12.445","article-title":"Human progenitor cells rapidly mobilized by AMD3100 repopulate NOD\/SCID mice with increased frequency in comparison to cells from the same donor mobilized by granulocyte colony stimulating factor","volume":"13","author":"Hess","year":"2007","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.omtm.2025.101558_bib28","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1182\/bloodadvances.2018027599","article-title":"Plerixafor alone for the mobilization and transplantation of HLA-matched sibling donor hematopoietic stem cells","volume":"3","author":"Chen","year":"2019","journal-title":"Blood Adv."},{"key":"10.1016\/j.omtm.2025.101558_bib29","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/trf.15037","article-title":"The feasibility and efficacy of subcutaneous plerixafor for mobilization of peripheral blood stem cells in allogeneic HLA-identical sibling donors: results of the HOVON-107 study","volume":"59","author":"de Greef","year":"2019","journal-title":"Transfusion"},{"key":"10.1016\/j.omtm.2025.101558_bib30","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1182\/blood-2016-09-739722","article-title":"Mobilization of allogeneic peripheral blood stem cell donors with intravenous plerixafor mobilizes a unique graft","volume":"129","author":"Schroeder","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2025.101558_bib31","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1182\/blood.V98.10.2900","article-title":"Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter?","volume":"98","author":"Korbling","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2025.101558_bib32","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1182\/blood-2003-02-0663","article-title":"Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist","volume":"102","author":"Liles","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2025.101558_bib33","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.bbmt.2013.10.013","article-title":"Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendations","volume":"20","author":"Giralt","year":"2014","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.omtm.2025.101558_bib34","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/j.bbmt.2020.04.013","article-title":"Current use of and trends in hematopoietic cell transplantation in the United States","volume":"26","author":"D'Souza","year":"2020","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.omtm.2025.101558_bib35","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cell.2017.11.003","article-title":"Rapid mobilization reveals a highly engraftable hematopoietic stem cell","volume":"172","author":"Hoggatt","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.omtm.2025.101558_bib36","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1182\/blood-2006-06-031401","article-title":"The chemokine GRObeta mobilizes early hematopoietic stem cells characterized by enhanced homing and engraftment","volume":"110","author":"Fukuda","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2025.101558_bib37","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41408-024-01152-1","article-title":"Phase II study of novel CXCR2 agonist and Plerixafor for rapid stem cell mobilization in patients with multiple myeloma","volume":"14","author":"Sidana","year":"2024","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.omtm.2025.101558_bib38","first-page":"33","article-title":"Stochastic fate decisions of HSCs after transplantation: early contribution, symmetric expansion, and pool formation","volume":"142","author":"Radtke","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2025.101558_bib39","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000001029","article-title":"Isolation of a highly purified HSC-enriched CD34(+)CD90(+)CD45RA(-) cell subset for allogeneic transplantation in the nonhuman primate large-animal model","volume":"6","author":"Radtke","year":"2020","journal-title":"Transplant. Direct"},{"key":"10.1016\/j.omtm.2025.101558_bib40","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.exphem.2018.12.003","article-title":"MISTRG mice support engraftment and assessment of nonhuman primate hematopoietic stem and progenitor cells","volume":"70","author":"Radtke","year":"2019","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.omtm.2025.101558_bib41","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.omtm.2020.07.010","article-title":"Purification of human CD34(+)CD90(+) HSCs reduces target cell population and improves lentiviral transduction for gene therapy","volume":"18","author":"Radtke","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2025.101558_bib42","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw3768","article-title":"Therapeutically relevant engraftment of a CRISPR-Cas9-edited HSC-enriched population with HbF reactivation in nonhuman primates","volume":"11","author":"Humbert","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2025.101558_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108093","article-title":"Controlled cycling and quiescence enables efficient HDR in engraftment-enriched adult hematopoietic stem and progenitor cells","volume":"32","author":"Shin","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.omtm.2025.101558_bib44","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature13420","article-title":"Targeted genome editing in human repopulating haematopoietic stem cells","volume":"510","author":"Genovese","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2025.101558_bib45","doi-asserted-by":"crossref","first-page":"6677","DOI":"10.1172\/JCI140189","article-title":"BCL11A enhancer-edited hematopoietic stem cells persist in rhesus monkeys without toxicity","volume":"130","author":"Demirci","year":"2020","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omtm.2025.101558_bib46","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1182\/bloodadvances.2020003714","article-title":"Single-dose MGTA-145\/plerixafor leads to efficient mobilization and in vivo transduction of HSCs with thalassemia correction in mice","volume":"5","author":"Li","year":"2021","journal-title":"Blood Adv."},{"key":"10.1016\/j.omtm.2025.101558_bib47","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1182\/bloodadvances.2024012757","article-title":"A simplified G-CSF-free procedure allows for in vivo HSC gene therapy of sickle cell disease in a mouse model","volume":"8","author":"Li","year":"2024","journal-title":"Blood Adv."},{"key":"10.1016\/j.omtm.2025.101558_bib48","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1016\/j.ymthe.2023.08.003","article-title":"CD90-targeted lentiviral vectors for HSC gene therapy","volume":"31","author":"Berckmueller","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2025.101558_bib49","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.ade6967","article-title":"In vivo hematopoietic stem cell modification by mRNA delivery","volume":"381","author":"Breda","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.omtm.2025.101558_bib50","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.cell.2021.12.021","article-title":"Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins","volume":"185","author":"Banskota","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.omtm.2025.101558_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109207","article-title":"Targeted delivery of CRISPR-Cas9 and transgenes enables complex immune cell engineering","volume":"35","author":"Hamilton","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.omtm.2025.101558_bib52","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1038\/s41587-023-02078-y","article-title":"Engineered virus-like particles for transient delivery of prime editor ribonucleoprotein complexes in vivo","volume":"42","author":"An","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtm.2025.101558_bib53","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13173","article-title":"Semi-automated closed system manufacturing of lentivirus gene-modified haematopoietic stem cells for gene therapy","volume":"7","author":"Adair","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2025.101558_bib54","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.omtm.2017.11.005","article-title":"A nonhuman primate transplantation model to evaluate hematopoietic stem cell gene editing strategies for beta-hemoglobinopathies","volume":"8","author":"Humbert","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2025.101558_bib55","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gku936","article-title":"Easy quantitative assessment of genome editing by sequence trace decomposition","volume":"42","author":"Brinkman","year":"2014","journal-title":"Nucleic Acids Res."}],"container-title":["Molecular Therapy Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050125001536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050125001536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T17:07:07Z","timestamp":1772903227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050125001536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2329050125001536"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2025.101558","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gro\u03b2T rapidly and reliably mobilizes primitive hematopoietic stem and progenitor cells in nonhuman primates","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2025.101558","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"101558"}}